BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30184317)

  • 1. Can Mitochondrial DNA be CRISPRized: Pro and Contra.
    Loutre R; Heckel AM; Smirnova A; Entelis N; Tarassov I
    IUBMB Life; 2018 Dec; 70(12):1233-1239. PubMed ID: 30184317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA.
    Tonin Y; Heckel AM; Dovydenko I; Meschaninova M; Comte C; Venyaminova A; Pyshnyi D; Tarassov I; Entelis N
    Biochimie; 2014 May; 100():192-9. PubMed ID: 23994754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-replicative recombinant 5S rRNA molecules can modulate the mtDNA heteroplasmy in a glucose-dependent manner.
    Loutre R; Heckel AM; Jeandard D; Tarassov I; Entelis N
    PLoS One; 2018; 13(6):e0199258. PubMed ID: 29912984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific CRISPR-based mitochondrial DNA manipulation is limited by gRNA import.
    Schmiderer L; Yudovich D; Oburoglu L; Hjort M; Larsson J
    Sci Rep; 2022 Nov; 12(1):18687. PubMed ID: 36333335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of CRISPR-Cas12a crRNAs into human mitochondria.
    Nikitchina N; Ulashchik E; Shmanai V; Heckel AM; Tarassov I; Mazunin I; Entelis N
    Biochimie; 2024 Feb; 217():74-85. PubMed ID: 37690471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient Mitochondrial Genome Editing by CRISPR/Cas9.
    Jo A; Ham S; Lee GH; Lee YI; Kim S; Lee YS; Shin JH; Lee Y
    Biomed Res Int; 2015; 2015():305716. PubMed ID: 26448933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial import, health and mtDNA copy number variability seen when using type II and type V CRISPR effectors.
    Antón Z; Mullally G; Ford HC; van der Kamp MW; Szczelkun MD; Lane JD
    J Cell Sci; 2020 Sep; 133(18):. PubMed ID: 32843580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells.
    Kolesnikova OA; Entelis NS; Jacquin-Becker C; Goltzene F; Chrzanowska-Lightowlers ZM; Lightowlers RN; Martin RP; Tarassov I
    Hum Mol Genet; 2004 Oct; 13(20):2519-34. PubMed ID: 15317755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing.
    Mok BY; de Moraes MH; Zeng J; Bosch DE; Kotrys AV; Raguram A; Hsu F; Radey MC; Peterson SB; Mootha VK; Mougous JD; Liu DR
    Nature; 2020 Jul; 583(7817):631-637. PubMed ID: 32641830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering.
    Eghbalsaied S; Lawler C; Petersen B; Hajiyev RA; Bischoff SR; Frankenberg S
    Gene Ther; 2024 May; 31(5-6):209-223. PubMed ID: 38177342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-mediated mutagenesis at microhomologous regions of human mitochondrial genome.
    Wang B; Lv X; Wang Y; Wang Z; Liu Q; Lu B; Liu Y; Gu F
    Sci China Life Sci; 2021 Sep; 64(9):1463-1472. PubMed ID: 33420919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized.
    Gammage PA; Moraes CT; Minczuk M
    Trends Genet; 2018 Feb; 34(2):101-110. PubMed ID: 29179920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting Perspective.
    Jackson CB; Turnbull DM; Minczuk M; Gammage PA
    Trends Mol Med; 2020 Jul; 26(7):698-709. PubMed ID: 32589937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA: Epigenetics and environment.
    Sharma N; Pasala MS; Prakash A
    Environ Mol Mutagen; 2019 Oct; 60(8):668-682. PubMed ID: 31335990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication stress in mitochondria.
    Ricchetti M
    Mutat Res; 2018 Mar; 808():93-102. PubMed ID: 29523336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrogating Mitochondrial Biology and Disease Using CRISPR/Cas9 Gene Editing.
    Tang JX; Pyle A; Taylor RW; Oláhová M
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in methods for reducing mitochondrial DNA disease by replacing or manipulating the mitochondrial genome.
    Rai PK; Craven L; Hoogewijs K; Russell OM; Lightowlers RN
    Essays Biochem; 2018 Jul; 62(3):455-465. PubMed ID: 29950320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presequence-Independent Mitochondrial Import of DNA Ligase Facilitates Establishment of Cell Lines with Reduced mtDNA Copy Number.
    Spadafora D; Kozhukhar N; Alexeyev MF
    PLoS One; 2016; 11(3):e0152705. PubMed ID: 27031233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNA.
    Tonin Y; Heckel AM; Vysokikh M; Dovydenko I; Meschaninova M; Rötig A; Munnich A; Venyaminova A; Tarassov I; Entelis N
    J Biol Chem; 2014 May; 289(19):13323-34. PubMed ID: 24692550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.